Fig. 2

sFGL2 levels in patients with HBV-related liver diseases and in healthy controls. sFGL2 levels were measured in study subjects and compared between subgroups. a: comparison between chronic patients with and without liver cirrhosis. b: comparison among different Child-Pugh groups of patients with liver cirrhosis. c: comparison between chronic patients with and without hepatocellular carcinoma. d: comparison of FGL2 mRNA expression in tumour and adjacent non-tumour tissues. e: FGL2 mRNA expression in stage-A and stage-B tumour and adjacent non-tumour tissues. Box plots illustrate medians with inter-quartile range. Comparisons of sFGL2 levels were performed using Mann-Whitney-Wilcoxon test or Kruskal-Wallis test, while comparisons of FGL2 mRNA relative expression were performed using Paired-samples t test